Nalan Demir

459 total citations
29 papers, 278 citations indexed

About

Nalan Demir is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Internal Medicine. According to data from OpenAlex, Nalan Demir has authored 29 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Epidemiology and 6 papers in Internal Medicine. Recurrent topics in Nalan Demir's work include Venous Thromboembolism Diagnosis and Management (6 papers), Pulmonary Hypertension Research and Treatments (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Nalan Demir is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (6 papers), Pulmonary Hypertension Research and Treatments (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Nalan Demir collaborates with scholars based in Türkiye, Cambodia and United States. Nalan Demir's co-authors include Nurdan Köktürk, Numan Ekim, İpek Kıvılcım Oğuzülgen, Oya Kayacan, Elif Şen, Gül Gürsel, Orçun Çiftci, Serhat Erol, Murat Turgay and Orhan Küçükşahin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Circulation Journal and Human Vaccines & Immunotherapeutics.

In The Last Decade

Nalan Demir

23 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nalan Demir Türkiye 10 92 88 58 40 38 29 278
Kalpit Devani United States 12 86 0.9× 72 0.8× 33 0.6× 63 1.6× 8 0.2× 42 361
Monil Majmundar United States 11 78 0.8× 136 1.5× 18 0.3× 222 5.5× 9 0.2× 70 439
Scott E. Janus United States 10 29 0.3× 67 0.8× 20 0.3× 119 3.0× 33 0.9× 33 332
Manon Belhassen France 13 253 2.8× 72 0.8× 25 0.4× 97 2.4× 14 0.4× 70 521
Yih-Ting Chen Taiwan 11 29 0.3× 35 0.4× 40 0.7× 22 0.6× 10 0.3× 25 411
Hui Yin Lim Australia 12 34 0.4× 47 0.5× 144 2.5× 107 2.7× 3 0.1× 56 399
Irena Begaj United Kingdom 11 90 1.0× 70 0.8× 39 0.7× 60 1.5× 4 0.1× 18 436
William Yoon United States 10 106 1.2× 32 0.4× 19 0.3× 66 1.6× 16 0.4× 23 305
Christine V. Kinnier United States 11 61 0.7× 44 0.5× 50 0.9× 79 2.0× 2 0.1× 24 378
Bernadette Corica Italy 15 53 0.6× 176 2.0× 65 1.1× 372 9.3× 5 0.1× 54 588

Countries citing papers authored by Nalan Demir

Since Specialization
Citations

This map shows the geographic impact of Nalan Demir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nalan Demir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nalan Demir more than expected).

Fields of papers citing papers by Nalan Demir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nalan Demir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nalan Demir. The network helps show where Nalan Demir may publish in the future.

Co-authorship network of co-authors of Nalan Demir

This figure shows the co-authorship network connecting the top 25 collaborators of Nalan Demir. A scholar is included among the top collaborators of Nalan Demir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nalan Demir. Nalan Demir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Demir, Nalan, et al.. (2024). A case of post traumatic mitral chordae rupture mimicking acute respiratory distress syndrome. World Journal of Emergency Medicine. 15(4). 322–322.
4.
Demir, Nalan, et al.. (2022). Reliability of Bigliani’s Classification using Magnetic Resonance Imaging for Determination of Acromial Morphology. Malaysian Orthopaedic Journal. 16(3). 44–49. 2 indexed citations
5.
Savaş, İsmail, et al.. (2018). Frequency of vitamin K oxidoreductase complex subunit-1 (VKORC1) polymorphisms and warfarin dose management in patients with venous thromboembolism. The Pharmacogenomics Journal. 18(5). 646–651. 1 indexed citations
6.
Çiledağ, Aydın, Gökhan Çelik, Nalan Demir, et al.. (2018). High serum YKL-40 level is associated with poor prognosis in patients with lung cancer. Tuberkuloz ve Toraks. 66(4). 273–279. 5 indexed citations
7.
Şen, Elif, et al.. (2017). Which factors effects patients belief and attitudes about influenza vaccination?. Tuberkuloz ve Toraks. 65(4). 308–316. 9 indexed citations
8.
Demir, Nalan, et al.. (2017). Alpha-1 Antitrypsin Levels and Polymorphisms in Interstitial Lung Diseases. TURKISH JOURNAL OF MEDICAL SCIENCES. 47(2). 476–482. 4 indexed citations
9.
Şen, Elif, et al.. (2017). Beliefs, attitudes, and activities of healthcare personnel about influenza and pneumococcal vaccines. Human Vaccines & Immunotherapeutics. 14(1). 111–117. 38 indexed citations
10.
Demir, Nalan, et al.. (2016). Kamu Sektöründe 6631 Sayılı İş Sağlığı Güvenliği Yasasının Uygulanması ve Mevcut Yükümlülükler. 8(29). 167–194. 2 indexed citations
11.
Küçükşahin, Orhan, Murat Turgay, Mustafa Turgut Yıldızgören, et al.. (2016). Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study. Clinical Rheumatology. 35(3). 663–666. 47 indexed citations
12.
Çiledağ, Aydın, Nalan Demir, Gökhan Çelik, et al.. (2015). Prognostic significance of serum vascular endothelial growth factor and Angiopoietin-2 in patients with lung cancer. Tuberkuloz ve Toraks. 63(2). 71–77. 7 indexed citations
13.
Demir, Nalan, et al.. (2014). Tuberculosis preventive treatment in a single medical center and evaluation of the results. Experimental and Therapeutic Medicine. 8(6). 1874–1878.
14.
Demir, Nalan, Ali Şahin, Orhan Küçükşahin, et al.. (2014). Pulmonary Arterial Hypertension and Systemic Sclerosis Relation: A Single Centre Experience. Heart Lung and Circulation. 23(7). 667–673. 8 indexed citations
15.
Çiledağ, Aydın, Akın Kaya, Adem İlkay Diken, et al.. (2014). The risk factors for late failure of non-invasive mechanical ventilation in acute hypercapnic respiratory failure. Tuberkuloz ve Toraks. 62(3). 177–182. 8 indexed citations
16.
Demir, Nalan. (2013). The Value of Cardiac Troponins in Diagnosis and Differential Diagnosis of Pulmonary Embolism. Journal of Pulmonary & Respiratory Medicine. 2(8). 2 indexed citations
17.
Demir, Nalan, et al.. (2011). Pulmonary alveolar proteinosis and successful therapy with combined lavage procedures: Case reports. Experimental and Therapeutic Medicine. 2(3). 569–573. 7 indexed citations
18.
Gürsel, Gül & Nalan Demir. (2006). Incidence and risk factors for the development of acute renal failure in patients with ventilator‐associated pneumonia. Nephrology. 11(3). 159–164. 15 indexed citations
19.
Köktürk, Nurdan, et al.. (2005). Fever in pulmonary embolism. Blood Coagulation & Fibrinolysis. 16(5). 341–347. 11 indexed citations
20.
Köktürk, Nurdan, et al.. (2004). A subglottic mass mimicking near-fatal asthma: a challenge of diagnosis. Journal of Emergency Medicine. 26(1). 57–60. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026